- Home
- IMVT vs VAC Comparison
IMVT vs VAC Comparison
Compare IMVT & VAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMVT
- VAC
- Stock Information
- Founded
- IMVT 2018
- VAC 1984
- Country
- IMVT United States
- VAC United States
- Employees
- IMVT N/A
- VAC N/A
- Industry
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- VAC Real Estate
- Sector
- IMVT Health Care
- VAC Finance
- Exchange
- IMVT Nasdaq
- VAC Nasdaq
- Market Cap
- IMVT 2.7B
- VAC 2.6B
- IPO Year
- IMVT N/A
- VAC N/A
- Fundamental
- Price
- IMVT $18.98
- VAC $67.30
- Analyst Decision
- IMVT Buy
- VAC Buy
- Analyst Count
- IMVT 9
- VAC 6
- Target Price
- IMVT $27.71
- VAC $90.50
- AVG Volume (30 Days)
- IMVT 1.7M
- VAC 399.5K
- Earning Date
- IMVT 11-06-2025
- VAC 11-05-2025
- Dividend Yield
- IMVT N/A
- VAC 4.72%
- EPS Growth
- IMVT N/A
- VAC 57.22
- EPS
- IMVT N/A
- VAC 6.65
- Revenue
- IMVT N/A
- VAC $3,378,000,000.00
- Revenue This Year
- IMVT N/A
- VAC $56.47
- Revenue Next Year
- IMVT N/A
- VAC $3.53
- P/E Ratio
- IMVT N/A
- VAC $10.06
- Revenue Growth
- IMVT N/A
- VAC 8.79
- 52 Week Low
- IMVT $12.72
- VAC $49.22
- 52 Week High
- IMVT $32.10
- VAC $100.32
- Technical
- Relative Strength Index (RSI)
- IMVT 68.15
- VAC 43.64
- Support Level
- IMVT $17.03
- VAC $62.37
- Resistance Level
- IMVT $18.34
- VAC $67.58
- Average True Range (ATR)
- IMVT 0.91
- VAC 2.12
- MACD
- IMVT 0.19
- VAC 0.37
- Stochastic Oscillator
- IMVT 88.86
- VAC 69.20
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
About VAC Marriott Vacations Worldwide Corporation
Marriott Vacations Worldwide Corp functions in the United States leisure industry. It owns and manages a cluster of resorts and accommodation facilities under trademarks like Marriott Vacation Club, Grand Residencies, and The Ritz-Carlton Destination Club predominantly in the United States. Some of its properties are also spread across Europe and Asia Pacific. Marriott's majority revenue components include the sale of vacation ownership products such as luxurious vacation packages. In addition, it offers purchase money financing to the end users of its core services. The company operates in two reportable segments: Vacation Ownership and Exchange & Third-Party Management. The majority of revenue is derived from the Vacation Ownership segment.